
    
      This study will require 24 months to be completed. Each child will participate for a period
      of time according to age of the 1st dose of vaccination: infants up to 6 months of age will
      be evaluated for 5 months; infants between 7 to 11 months will be evaluated for 3 months;
      children between 12 months up to 9 years of age will be evaluate for 2 months
    
  